This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Array Biopharma Inc.. Active years: 2016-2019.
Company Filing History:
Years Active: 2016-2019
Title: Kurtis D Davies: Innovator in Cancer Therapeutics
Introduction
Kurtis D Davies is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of cancer therapeutics, particularly through his innovative work on checkpoint kinase inhibitors.
Latest Patents
Kurtis holds 2 patents that focus on the combination of checkpoint kinase 1 inhibitors and WEE1 kinase inhibitors. His latest patents include a combination of a CHK1 inhibitor and a WEE1 inhibitor, which are designed to enhance the efficacy of cancer treatments.
Career Highlights
Kurtis D Davies has established himself as a key figure in the pharmaceutical industry. He is currently associated with Array Biopharma Inc., where he continues to develop groundbreaking therapies aimed at improving patient outcomes in oncology.
Collaborations
Throughout his career, Kurtis has collaborated with esteemed colleagues, including Stefan D Gross and Stefan Gross, to advance research in cancer treatment.
Conclusion
Kurtis D Davies exemplifies the spirit of innovation in the field of cancer therapeutics, with his patents paving the way for new treatment possibilities. His work continues to inspire advancements in medical science.